Since the interventions were quite different, and not all outcomes were measured by both studies, it is quite difficult to compare the trials. Those who filled in the booklet showed no decrease in admission to hospital (voluntary or involuntary) or contact with outpatient services, when compared to usual care. The high intensity group showed no differences in voluntary admissions compared to those in usual care, but were less likely to be hospitalised involuntarily, or assessed under the Mental Health Act. They were also less likely to be violent. There was no difference in use of psychiatric out-patient services by those in the intervention groups. These are small studies and more research is needed, but it is suggested that using an advance treatment directive could be an alternative to community treatment orders.
(Plain language summary prepared for this review by Janey Antoniou of RETHINK, UK www.rethink.org)
B A C K G R O U N D Description of the intervention
An advance directive is a document that specifies a person's preferences for treatment, should he or she lose capacity to make treatment decisions in the future. They are sometimes termed 'Ulysses directives' in reference to the Greek hero's encounter with the Sirens. The Sirens lived on a rocky island in the sea, and were notorious for their enchanted singing, luring many unwary sailors to shipwreck. Ulysses instructed his crew to stuff their ears with wax and tie him to the mast of his ship so he could hear their song but not be lured onto the rocks while under their spell. Advance directives allow the physician to respect the patient's prior competent instructions when these conflict with those expressed while incompetent (Ritchie 1998) . Mental health advance directives are intended to convey a person's preferences for psychiatric treatment should the person become incompetent in the future and unable to do so for themselves. Advance directives have been most commonly used in end-of-life care settings to direct medical care treatment decisions. They are, however, well-suited to mental health settings. Severe mental illnesses, such as psychosis, mania, or severe depression, are characterized by alternating periods of competence and incompetence. Advance directives provide people with these illnesses the opportunity to convey their treatment preferences when they are competent. There are two general forms of mental health advance directives, the instructional directive and the proxy directive (US GAO 1995) . A third form, the hybrid directive, combines the advantages of the instructional and proxy directives (La Fond 2002) . Instructional mental health advance directives communicate instructions for treatment providers in the event of a mental health crisis, should the patient become incompetent and unable to do so themselves. They may contain decisions regarding hospitalisation, methods for handling emergencies (such as use of restraint, seclusion, or sedation), medication (including types of medications to be used, dosages, methods and timing of administration), treatment approaches (such as electroconvulsive therapy or psychotherapy), persons to be notified in the event of hospitalisation, persons responsible for childcare, personal, and financial matters, and medical care issues (Srebnik 1999) . Proxy directives are health care power of attorney documents, which allow the patient to designate someone else to make decisions on his or her behalf should the patient become incompetent. As it is difficult to anticipate future events with enough specificity to provide adequate instructions, proxy directives are used more frequently than instructional directives. Proxy directives allow the designated proxy to take into account the actual circumstances of the patient's situation. Depending upon the terms of the directive, the proxy will make decisions using a 'substituted judgment' standard, or using a 'best-interest' standard (Srebnik 1999) . Hybrid directives name an individual who is authorised to make treatment decisions on behalf of the patient while also providing instructions to that person, combining the specificity of the instructional directive with the flexibility of the proxy decisionmaker (La Fond 2002 , Srebnik 1999 .
How the intervention might work
The effects of advance directives in the mental health setting are unclear, including the degree of subsequent compliance (Srebnik 1999) . Authors have suggested benefits in the following areas: a. Enhanced autonomy and choice for patients, with subsequent benefits to physical and psychological well-being; b. Improved family relationships through the reduction of conflict around treatment; c. Increased acceptance by service providers of patient autonomy; and/or d. Reduced service use including hospital admissions, bed-days, use of mental health legislation and contact with the criminal justice system.
Why it is important to do this review
There has, however, been little in the way of research into the effects of advance directives in any of these areas. We do not know the circumstances that promote compliance with directives and this is complicated by the fact that compliance is generally not dichotomous. Some aspects of directives may be complied with in some circumstances. There are more data on the effects on health service use, but results have been equivocal (Papageorgiou 2002 , Henderson 2004 . Some of the disparities in results may be due to differences in the sample including selection bias or in the type of intervention (Kisely 2005) . More intense interventions, including a lengthy interview with patients and their carers (Henderson 2004) appear to be more effective than providing patients with a booklet for completion (Papageorgiou 2002) . Other concerns about advance directives include situations where patients may agree to some treatments in their advance directives, but not others, even when they may be more appropriate for the patient (Ritchie 1998). One solution is to involve third parties in the agreement (Henderson 2004) . Although this may be associated with better outcomes in terms of health service use, this may add to their complexity and undermine the very autonomy that advance directives are designed to protect (Ritchie 1998). Another problem concerns the issue of who should decide whether a patient is actually competent when they formulate their advance directive -the treating physician or the courts (Ritchie 1998). A related issue is the patient's cognitive and mental state when making an advance directive. Competence relies on an individual's ability to process, evaluate and apply information but, for example, feelings of hopelessness secondary to depression may lead individuals to underestimate the effectiveness of available treatments. Solutions include careful documentation of competence at the time of the directive, or the addition of a rider stating that in the event of incompetence, the patient's proxy would be mandated to override their treatment decisions not judged to be in the patient's best interests.
O B J E C T I V E S
We examined the effects of advance treatment directives compared with standard care for people with severe mental illness.
This review was limited to randomised controlled trials (RCTs) as these remain the least biased method of evaluating effects of all types of interventions. We excluded quasi-randomised studies, such as those allocating by using alternate days of the week.
Types of participants
We included adults with severe mental illness (schizophrenia and other psychotic disorders, bipolar disorder, or depression with psychotic features) however diagnosed, who were managed in a community setting. We did not consider substance abuse a severe mental disorder in its own right, however, studies were eligible if they included people with dual diagnoses, that is those with severe mental illness and substance abuse.
Types of interventions
1. For an intervention to be accepted as an advance directive, it had to be described using the following terms: a. Advance directive b. Joint crisis planning c. Advance crisis planning d. Anticipatory psychiatric planning e. Ulysses directive 2. Standard care We defined this as any usual care not involving an advance directive.
Types of outcome measures
We grouped outcomes into the short term (up to 12 weeks), medium term (13 to 26 weeks) and long term (over 26 weeks). 
Searching other resources

Reference searching
We also inspected the references of all identified studies (including those rejected from the review) for more studies. 2. Personal contact We contacted the first author of each included study and known experts who had published reviews in the field for information regarding unpublished trials and extra data on the published trials.
Data collection and analysis
Selection of studies
We (LAC, SK) independently inspected all reports. In order to prevent any bias, we printed out a list of all titles and abstracts excluding the author's names, institutions, and journal titles. We resolved any disagreement by discussion, and where doubt remained, we acquired the full article for further inspection. Once the full articles were obtained, we independently decided whether the studies met the review criteria. A record of all rejected papers and the reasons for rejection was kept.
Data extraction and management
1. Data extraction LAC and SK independently undertook data extraction. Any disagreements were discussed, the decisions documented and where necessary, the authors of the studies contacted to help resolve the issue.
Management
We extracted data onto standard, simple forms. 3. Scales A wide range of instruments are available to measure mental health outcomes. These instruments vary in quality and many are not valid, and are known to be subject to bias in trials of treatments for schizophrenia (Marshall 2000) . Therefore continuous data from rating scales were included only if the measuring instrument had been described in a peer-reviewed journal.
Assessment of risk of bias in included studies
We assessed the methodological quality of included studies using the criteria described in the Cochrane Handbook (Higgins 2006), which is based on the degree of allocation concealment. Poor concealment has been associated with overestimation of treatment effect (Schulz 1995) Category A includes studies in which allocation has been randomised and concealment is explicit. Category B studies are those which have randomised allocation but in which concealment is not explicit. Category C studies are those in which allocation has neither been randomised nor concealed. Only trials that are stated to be randomised (categories A or B of the handbook) will be included in this review. The categories are defined below:
A. Low risk of bias (adequate allocation concealment) B. Moderate risk of bias (some doubt about the results) C. High risk of bias (inadequate allocation concealment). When disputes arose as to which category a trial should be allocated, again resolution was attempted by discussion. When this was not possible we did not enter the data and the trial was added to the list of those awaiting assessment until further information could be obtained.
Measures of treatment effect
1. Binary data Where possible, efforts were made to convert outcome measures to binary data. This can be done by identifying cut-off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It was generally assumed that if there had been a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, Overall 1962) or the Positive and Negative Syndrome Scale (PANSS,Kay 1986), this could be considered as a clinically significant response (Leucht 2005a , Leucht 2005b . Similarly, we considered a rating of 'at least much improved' according to the Clinical Global Impression Scale (Guy 1976) as a clinically significant response. It was recognised that for many people, especially those with chronic or severe illness, a less rigorous definition of important improvement (e.g. 25% on the BPRS) would be equally valid. If individual patient data were available, the 50% cut-off was used for the definition in the case of non-chronically ill people and 25% for those with chronic illness. If data based on these thresholds were not available, we used the primary cut-off presented by the original authors. 2. Continuous data 2.1 Normal distribution Continuous data on outcomes in trials relevant to mental health issues are often not normally distributed. To avoid the pitfall of applying parametric tests to non-parametric data we applied the following standards to continuous final value endpoint data before inclusion: (a) standard deviations and means were reported in the paper or were obtainable from the authors; (b) when a scale started from zero, the standard deviation, when multiplied by two, should be less than the mean (otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution -Altman 1996); In cases with data that are greater than the mean they were entered into 'Other data' table as skewed data. If a scale starts from a positive value (such as PANSS, which can have values from 30 to 210) the calculation described above in (b) should be modified to take the scale starting point into account. In these cases skew is present if 2SD>(S-Smin), where S is the mean score and Smin is the minimum score. We reported non-normally distributed data (skewed) in the 'other data types' tables. For change data (mean change from baseline on a rating scale) it is impossible to tell whether data are non-normally distributed (skewed) or not, unless individual patient data are available. After consulting the ALLSTAT electronic statistics mailing list, we entered change data in RevMan analyses and reported the finding in the text to summarise available information. In doing this, we assumed either that data were not skewed or that the analysis could cope with the unknown degree of skew. 2.2 Final endpoint value versus change data Where both final endpoint data and change data were available for the same outcome category, only final endpoint data were presented. We acknowledge that by doing this much of the published change data may be excluded, but argue that endpoint data is more clinically relevant and that if change data were to be presented along with endpoint data, it would be given undeserved equal prominence. Where studies reported only change data we contacted authors for endpoint figures. 3. General Where possible, we entered data in such a way that the area to the left of the line of no effect in the forest plots indicated a favourable outcome for advance treatment directives.
Unit of analysis issues
1. Cluster trials Studies increasingly employ cluster randomisation (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intraclass correlation in clustered studies, leading to a unit of analysis error (Divine 1992) whereby p values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This causes Type I errors (Bland 1997 , Gulliford 1999 . Where clustering was not accounted for in primary studies, we presented the data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review we will seek to contact first authors of studies to obtain intraclass correlation coefficients of their clustered data and to adjust for this using accepted methods (Gulliford 1999). Where clustering has been incorporated into the analysis of primary studies, we will also present these data as if from a non-cluster randomised study, but adjusted for the clustering effect. We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a design effect. This is calculated using the mean number of participants per cluster (m) and the intraclass correlation coefficient (ICC) [Design effect=1+(m-1)*ICC] (Donner 2002). If the ICC was not reported it was assumed to be 0.1 (Ukoumunne 1999). If cluster studies had been appropriately analysed taking into account intraclass correlation coefficients and relevant data documented in the report, we synthesised these with other studies using the generic inverse variance technique.
Dealing with missing data
In the event of more than 35% of those originally randomised being lost to follow-up, the data from that particular outcome were not included in this review. We conducted an intention-totreat analysis, including all participants who were randomised, and in the case of (Papageorgiou 2002), only those who had been discharged from hospital. We assumed that those who dropped out had the negative outcome.
Assessment of heterogeneity
Firstly, we considered all the included studies within any comparison to judge for clinical heterogeneity. Then we visually inspected graphs to investigate the possibility of statistical heterogeneity. We supplemented this by using primarily the I-squared statistic. This provides an estimate of the percentage of variability due to heterogeneity rather than chance alone. Where the I-squared estimate was greater than or equal to 50%, we interpreted this as indicating the presence of considerable levels of heterogeneity (Higgins 2003) . When heterogeneous results were found, we investigated the reasons for this; where heterogeneity substantially altered the results these data were not summated, but presented separately and reasons for heterogeneity investigated.
Assessment of reporting biases
Again, according to the protocol (Campbell 2006), we planned to plot data from all included studies in a funnel graph (plotting trial effect against trial size) in an attempt to investigate the likelihood of overt publication bias (Egger 1997). However, with only 2 studies included in the review, we were unable to use this technique.
Data synthesis
Where possible we employed a fixed-effect model for analyses. We understand that there is no closed argument for preference for use of fixed or random-effects models. The random-effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This does seem true to us, however, random-effects does put added weight onto the smaller of the studies -those trials that are most vulnerable to bias. For this reason we favour using fixed-effect models For binary outcomes we calculated the relative risk (RR) and its 95% confidence interval (CI) based on the fixed-effect model. Relative Risk is more intuitive (Boissel 1999) than odds ratios and odds ratios tend to be interpreted as RR by clinicians (Deeks 2000) This misinterpretation then leads to an overestimate of the impression of the effect. When the overall results were significant we calculated the number needed to treat (NNT) and the number needed to harm (NNH). For continuous outcomes we estimated a weighted mean difference (WMD) between groups based on a fixed-effect model.
Subgroup analysis and investigation of heterogeneity
If data are clearly heterogeneous we checked that data are correctly extracted and entered and that we had made no unit of analysis errors. If the high levels of heterogeneity remained we did not undertake a meta-analysis at this point for if there is considerable variation in results, and particularly if there is inconsistency in the direction of effect, it may be misleading to quote an average value for the intervention effect.
Sensitivity analysis
We investigated factors that may lead to differences between the results of individual studies using sensitivity analyses. We specified potential sources of heterogeneity in advance. These included: variations of types of intervention (e.g. advance directives -instructional, proxy, or hybrid, joint crisis planning, advance crisis planning, or anticipatory psychiatric planning), intensity of intervention (low vs. high intensity e.g. information booklet and checklist vs. family meeting with patient present), and variations in methodological quality such as adequate descriptions of reasons for dropout (e.g. high vs. low methodological quality).
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
Results of the search
Our search in the Cochrane Schizophrenia Group's Register (February 2008) and the other databases identified 485 potentially relevant papers, of which we identified 54 papers for further inspection. Only two studies met the inclusion criteria for this review.
Included studies
We were able to include two studies involving 321 participants (Henderson 2004 , n=160, Papageorgiou 2002 a joint crisis plan formulated by the patient, care coordinator, psychiatrist and project worker. The plan contained contact information, details of mental and physical illnesses, treatments, indicators for relapse, and advance statements of preferences for care in the event of future relapse. The directives were formulated by patients along with carers, friends, or advocates in conjunction with their mental health care providers. Participants in the (Papageorgiou 2002) study were provided with a booklet entitled "Preferences for care", in which participants were encouraged to complete seven statements outlining future preferences for treatment. Participants could complete and sign the statements themselves, or dictate their wishes to a researcher. 6. Outcomes The main outcomes in the Henderson 2004 study were admission to hospital, bed days, and use of the Mental Health Act over 15-month follow-up. Secondary outcomes included adverse events such as self harm and violence. Papageorgiou 2002 captured rate of compulsory readmissions over 12-month follow-up as the main outcome measure. Secondary outcomes included time spent in hospital compulsorily or voluntarily, reported symptoms of mental illness according to the Basis-32, prescribing, patients' satisfaction with service delivery, and patients' ability to make decisions for themselves. 6.1 Basis-32 (Eisen 1994) The BASIS-32 measures the change in self-reported symptoms over the course of treatment. The instrument assesses treatment outcomes from the patient perspective, for a wide range of symptoms and problems that occur across the diagnostic spectrum. Scoring the 32 items provides summary and sub-scale (Relation to Self and Others, Depression and Anxiety, Daily Living and Role Functioning, Impulsive and Addictive Behavior, Psychosis) scores of how patients feel before and after receiving care. The survey measures the degree of difficulty experienced by the patient over a one-week period on a five-point scale ranging from no difficulty to extreme difficulty. Papageorgiou 2002 reported data from this scale. 6.2 Hospital Service Satisfaction Scale The Hospital Service Satisfaction Scale is an adapted brief version of the Verona Satisfaction Scale (Ruggeri 1993), which is an instrument aimed at measuring expectations and satisfaction of patients, relatives, and professionals with community-based psychiatric services in a multidimensional, sensitive, valid and reliable way. It is not clear whether the Hospital Service Satisfaction Scale itself was validated. Papageorgiou 2002 reported data from this scale. 7. Missing outcomes We found no data for the following outcomes: social functioning, imprisonment, employment time to relapse quality of life, self esteem, or carer/family satisfaction Excluded studies 1. Excluded studies We excluded 52 studies from the review. Many were not randomised trials (n=37), and several were people not with mental health issues but those at the end of their lives (n=9). For two the studies were of interventions other than those of interest, in three outcomes were not of interest to this review, and for one study we were unable to obtain data for meta-analysis. 2.Studies awaiting assessment There are no studies awaiting assessment. 3.Ongoing Studies We know of no ongoing studies.
Risk of bias in included studies
1. Loss to follow-up All participants in the Henderson 2004 study were included in the data analyses using an intention-to-treat analysis. No systematic differences were present in the participants who left the study early between the two study groups. Papageorgiou 2002 reported the reasons for participant withdrawal, with all participants accounted for, and no systematic differences emerged between intervention groups.
Allocation
Henderson 2004 determined allocation sequence using minimisation, stratified by team and severity of patients' condition to ensure even distribution of those features. When predictability of allocation became possible due to batches of similar patients being allocated, the authors reassigned the allocation of one patient chosen at random before reverting to minimisation. Papageorgiou 2002 allocated patients randomly using a block design, stratified according to whether this was the patient's first ever or subsequent sectioning. Henderson 2004 reported that only 36% of eligible patients agreed to participate.
Blinding
Henderson 2004 reported that one investigator collected followup data and was blinded to treatment group. Neither participants nor staff could be blinded to allocation due to the nature of the intervention. Papageorgiou 2002 stated that they were unable to blind the research assistants to the patients' allocation as they assisted patients in the intervention group with their directives. The trial authors noted that it was unlikely that systematic bias was introduced, as the primary outcome was compulsory hospital admission and was not based on assessment by the researchers.
Incomplete outcome data
The studies reported losses to follow-up of approximately 25% in both intervention and control groups. Henderson 2004 conducted intention-to-treat analyses of all participants randomised. Papageorgiou 2002 conducted analyses for all participants randomised except for those never eventually discharged (one in the intervention group, four in the control group). In this review, in the case of Papageorgiou 2002, we used a sensitivity analysis to determine if including those who were never discharged made any difference to the results. As including the five people never discharged made no difference to the results, they have been omitted.
Selective reporting
The first authors of both studies were helpful in providing additional data for the review. Due to skew, however, Papageorgiou 2002 reported grouped medians rather than means.
Other potential sources of bias
We did not identify any other potential sources of bias. We found a reduction in the intervention group (n=160, RR 0.69 0.5 to 1.0) compared with the control but this failed to reach statistical significance (p=0.08). 1.3 Involuntary psychiatric admissions within 15 months 1.3.1 Number of participants re-admitted involuntarily Overall, we found no significant difference in compulsory readmissions between the intervention and treatment groups (n=316, 2 RCTs, RR 0.67 CI 0.4 to 1.1).
Effects of interventions
Number of participants with 1-100 days subsequent involuntary admission
We found that participants in the intervention group were no less likely to have short (1-100 days) subsequent involuntary admissions than those in the control group (Papageorgiou 2002 , n= 156, RR 0.70 CI 0.3 to 1.5). 1.3.3 Number of participants with >100 days subsequent involuntary admission Similarly we found participants with advance directives were no less likely to have long (more than 100 days) subsequent involuntary admission than those in the control group (Papageorgiou 2002, n=156, RR 2.44 CI 0.5 to 12.2). 1.4 Voluntary admissions within 15 months 1.4.1 Number of participants re-admitted voluntarily We found no significant difference between the intervention and control groups in terms of the number of participants with voluntary re-admissions (n=316, 2 RCTs, RR 1.03 CI 0.6 to 1.7). 1.4.2 Number of participants with 1-100 days subsequent voluntary admission Papageorgiou 2002 investigated whether there were any effects of advance directives on voluntary short admissions (<100 days). We found data to be equivocal between intervention and control groups for voluntary admissions of fewer than 100 days (n=156, RR 0.89 CI 0.5 to 1.5). 1.4.3 Number of participants with >100 days subsequent voluntary admission Papageorgiou 2002 also reported voluntary long admissions (>100 days). Again, we found no significant differences between intervention and control groups for voluntary admissions of greater than 100 days (n=156, RR 1.14 CI 0.4 to 3.2).
Involuntary bed days
We found no significant differences between participants given advanced treatment directives (Henderson 2004, n=31, WMD -3.08 CI -66.8 to 60.6) and the usual care group whilst on section at any point during their admission. Averaging involuntary bed days among the entire study population (n=160) did not achieve a statistically significant difference between intervention and control groups (n=160, WMD -16.52 CI -34.7 to 1.6). 1.6 Outpatient contacts Advanced treatment directives did not significantly reduce the number of psychiatric outpatient attendances compared with those given usual care (Henderson 2004 cited in Flood 2006, n= 160, WMD -0.10 CI -0.72 to 0.52), or community psychiatric nurse contacts (n=160, 1 RCT, WMD 15.00 CI -75.5 to 105.5), nor the number of psychiatric day service contacts (n=160, 1 RCT, WMD -0.50 CI -3.8, 2.8), and other community day centre contacts (n=160, 1 RCT, WMD -8.00 CI -18.0, 2.0). We found participants given advanced treatment directives were significantly less likely to have been assessed under the Mental Health Act (n= 160, WMD -0.20 CI -0.3 to -0.1). 1.7 Compliance with mental health treatment Data concerning compliance with mental health treatment (scored on a scale from 0 to 6) were available from Henderson 2004. We found no significant difference between advanced treatment directives (n=121, WMD -0.10 CI -0.6 to 0.4) and usual care. 1.8 Self harm Only Henderson 2004 reported data for self harm. We found no significant difference in self harm between intervention and control groups (n=160, RR 0.14 CI 0.02 to 1.1). 1.9 Violence Again, only Henderson 2004 reported data for violence as an outcome measure. We found a statistically significant difference in violence between the intervention and control arms (n=160, RR 0.27 CI 0.1 to 0.9), with those in the intervention arm less likely to be violent than those in the control arm (NNT 8 CI 6 to 92). 1.10 Criminal justice contacts These data were only available from the Flood 2006 citation of Henderson 2004 (n=160). We found no significant difference between the advanced treatment directives and usual care in the number of arrests (WMD -0.10 CI -0.3 to 0.12), lawyer contacts (WMD 0.00 CI -0.5 to 0.5), contacts with the police (WMD -0.20 CI -0.6 to 0.2), and nights in a police cell (WMD 0.00 CI -0.1 to 0.1) or prison (WMD -6.60 CI -16.7 to 3.5).
Social services
We found data from the Flood 2006 paper favoured advanced treatment directives for the outcome of 'fewer social work hours' (n=160, WMD -106.00 CI -156.2 to -55.8). The number of weeks spent in specialised accommodation (n=160, WMD 0.10 CI -0.02 to 0.2) were not significantly different between intervention groups. 1.12 Other health services Henderson 2004 found that the intervention group spent significantly more days in non-psychiatric facilities compared to the control group (n=160, WMD 15.50 CI 9.8 to 21.2). Otherwise there were no significant differences between the intervention and control groups in terms of the number of non-psychiatric outpatient visits (WMD -15.00, 95% CI -37.1 to 7.1), emergency department visits for either non-psychiatric problems (WMD -0.10 CI -0.3 to 0.1) or psychiatric problems (WMD -0.10 CI -0.2 to 0.04), general practitioner visits (WMD 0.60 CI -0.4 to 1.6), or number of different medications prescribed (WMD 0.20 CI -0.3 to 0.7). 1.13 Leaving the study early We found no significant differences in attrition rates between advanced treatment directives (n=316, 2 RCTs, RR 1.08 CI 0.8 to 1.4) and those given usual care. 2. Sensitivity analyses and publication bias We were only able to obtain data from a maximum of one study for most outcomes. Therefore we could not undertake sensitivity analyses as described in the protocol for variations in types of intervention (e.g. advance directives (instructional, proxy, or hybrid), joint crisis planning, advance crisis planning, or anticipatory psychiatric planning), intensity of intervention (low versus high intensity of intervention, e.g. information booklet and checklist versus family meeting with patient and clinician present), and variations in methodological quality such as adequate descriptions of reasons for dropout (high versus low methodological quality). Similarly, it was not possible to examine publication bias given the small number of studies identified. For the involuntary admissions outcome, however, participants in the comparatively higher-intensity joint crisis plan intervention group in the Henderson 2004 study were less likely to be re-admitted involuntarily after 15 months of follow-up than their peers in the control group (n=160, RR 0.48 CI 0.2 to 1.0). In contrast, we found no difference in involuntary re-admissions between the lower-intensity advance directive intervention and control groups in the Papageorgiou 2002 study (n=156, RR 0.91 CI 0.5 to 1.7). Data were also available from both included studies for the voluntary admissions outcome. There were no differences between intervention and control groups in either of the studies.
Missing outcomes
We found no data on social functioning, imprisonment, employment, time to relapse, quality of life, self esteem, accommodation status, or carer/family satisfaction. We were also unable to group outcomes into the short term (up to 12 weeks) and medium term (13 to 26 weeks). All data reported by the two included studies were for long-term outcomes.
D I S C U S S I O N
Summary of main results
General
Advance directives are used most often in end-of-life care, where they have been shown to increase expression of patient treatment preferences (Hanson 1997) . Advance directives are well suited to the mental health setting for the purpose of conveying patients' treatment preferences should they become unable to articulate them in the future. However, few randomised controlled trials to examine the effects of mental health advance directives have been conducted. In this systematic search for trials, only two studies met inclusion criteria. The intervention utilised in the (Henderson 2004) study were more intensive, with participants in the intervention group in receipt of joint crisis planning involving patient, family, friend, carer or other and the project worker. By contrast, patients in the (Papageorgiou 2002) study received a booklet containing statements of preferences for future treatment. 2. Specific -Comparison: ADVANCE DIRECTIVES versus USUAL CARE 2.1 Death During the long term follow up there were few deaths. Three that did occur were attributed to suicide but were not suggestive of any effect of advance directives.
Psychiatric admissions -primary outcome
Results for overall admissions were only available from Henderson 2004 and these failed to achieve statistical significance (p=0.08). In this small trial (n=160) there were, nevertheless, less admissions in the advance directive group (24 vs 35). This finding alone is encouraging of the need for further trials. Both studies provided data for the number of participants re-admitted involuntarily over the follow-up period. While the combined estimate did not demonstrate a significant difference in involuntary re-admissions between intervention and control groups, there was also some suggestion that advance directives did decrease these events. The Henderson 2004 study did indicate that participants in the intervention group were less likely to be hospitalised involuntarily during the follow-up period. This might have been because the low participation rate in the Henderson 2004 study (36%) could have lead to selection of participants with better prognoses. Another explication may be the intensity of the intervention. In the Henderson 2004 study, plans were developed at a 30-60 minute meeting with the researcher, treating team, patient, and invited relative. In Papageorgiou 2002 participants were only given booklets with seven statements regarding future preferences for treatment for completion. Nevertheless, this finding also suggests a moderate effect of the advance directives. Data concerning length of subsequent involuntary admissions were only available from Papageorgiou 2002. This study found no significant difference between intervention and control groups. Papageorgiou 2002 noted that there were fewer participants involuntarily re-admitted than predicted in both arms. While it would appear that intensity of treatment may be associated with an effect on subsequent involuntary admissions, it is problematic to draw firm conclusions from such limited data -with the exception that more studies are indicated. We found no difference between intervention and control groups for either the number of participants re-admitted voluntarily, or for the length of voluntary admissions. In the case of Papageorgiou 2002, the lack of evidence of a difference may be due to the lower intensity of the intervention. For the Henderson 2004 study, its power is reduced by a lower than anticipated admission rate in the control group. 2.3 Involuntary bed days Data were only available in this format from Henderson 2004. We found no evidence to suggest a difference in involuntary bed days between intervention and control groups, either among those on a section at any point during their admission, or among the entire sample. However, the rate of hospital admission among the control group is lower than expected based upon their earlier pilot study results, reducing the power of the study to detect a difference between the groups. 2.4 Outpatient contacts Overall, advance treatment directives did not reduce the number of outpatient contacts when assessed in various settings, but participants were less likely to be assessed under the Mental Health Act. This single finding is important but should be replicated.
Compliance with mental health treatment
There is no evidence of effect of advance directives (in the form of joint crisis planning) on compliance with mental health treatment, as measured on a scale from 1 to 6. Again, data for this outcome were only available from one study (Henderson 2004) , and more data is needed before conclusions can be drawn. 2.6 Self harm There is no evidence of an effect of advance directives (as joint crisis planning) on episodes of self harm. Data for this outcome were only available from one study (Henderson 2004). 2.7 Other outcomes Participants in the intervention group were less likely to commit acts of violence than those in the control group. By contrast, they had more inpatient days in non-psychiatric facilities. The explanations for these findings are unclear. On one hand, they may represent a good outcome in that participants required less social work assistance as they were better. Alternatively, it could mean that they were not receiving sufficient service. The same uncertainty applies to the finding that participants with advance directives spent more inpatient days in non-psychiatric facilities. Either way, data for these outcomes were only available from Henderson 2004 and so require replication. 2.8 Leaving the study early Long-term studies in people with mental illnesses typically suffer from high study attrition -the studies reported losses to follow up of approximately 25% in both the intervention and control groups. No differences were found between the two intervention groups. Participants were followed up in both studies with most being accounted for, although part of the data is based on an intention-to-treat analysis, and therefore assumptions were made for participants at their last assessment. This leads to potentially biased results.
Overall completeness and applicability of evidence
Applicability
The two studies included participants with severe mental illness (diagnosis of psychosis or bipolar affective disorder without psychotic symptoms, psychiatric inpatients), where recurrence of illness is common and for whom advance directives would be most appropriate.
Homogeneity
In the studies there is methodological heterogeneity due to differences in intensity of the interventions offered in the two studies. The Chi-square test for statistical heterogeneity for the main outcome, number of participants re-admitted involuntarily, did not reach significance (Chi-square=1.88, df=1, p=0.17), probably due to the very small number of studies. The I-square statistic for the main outcome, which approximates the proportion of total variation in study estimates due to heterogeneity rather than chance (sampling error), was 47%, indicating a moderate level of statisti-cal heterogeneity. Chi-square test for statistical heterogeneity for the other main outcome, number of participants re-admitted voluntarily, also did not reach significance (Chi-square=0.01, df=1, p=0.91). The I-square statistic for number of participants with voluntary re-admissions was 0%, indicating no statistical heterogeneity.
Quality of the evidence
We had hoped to report on the effects of advance directives on social functioning, imprisonment, employment, time to relapse, quality of life, self esteem, accommodation status, and carer/family satisfaction, however data were not reported for these outcomes. The included studies did not report data for many of the same outcomes, and reported the main outcomes differently, thus precluding several meta-analytic analyses. Also, the included trials are both small (largest n=160) and are likely underpowered due to fewer than anticipated admissions post-intervention.
Potential biases in the review process
Advance directive interventions are varied, encompassing interventions of varying intensity. We had planned to assess the contribution of the intensity of the intervention on the identified outcomes by means of sensitivity analyses. However, only two trials were identified, of which one was high-and the other low-intensity.
Agreements and disagreements with other studies or reviews
We know of no other systematic reviews in this area.
A U T H O R S ' C O N C L U S I O N S
Implications for practice 1. For people with severe mental illness Evidence for the effects of mental health advance directives is limited by the paucity of data available from randomised controlled trials. In a non-randomised study examining the effects of advance directives on working alliance and treatment satisfaction, participants in the intervention group showed significantly greater improvement in their working relationship with their clinicians, and were more likely to report satisfaction with their mental health treatment at one-month follow-up (Swanson 2006c). Currently it is not possible to recommend advance treatment directives for people with severe mental illness due to the lack of supporting data.
For clinicians
Results of this review suggest that more intensive interventions, such as joint crisis planning, may be of benefit in terms of reduction of involuntary readmissions or assessments under the Mental Health Act. This is consistent with the literature on advance directives in end-of-life care Successful end-of-life treatment planning has been associated with a process-rather than product-oriented approach and has been directed by the family or community rather than the physician (Prendergast 2001). However, caution in interpreting this finding is necessary, based on the lack of available randomised controlled trial data.
A qualitative analysis of a randomised controlled trial of psychiatric advance directives (PADs) reported that while PADs were tools for empowerment and self-determination, limited knowledge of PADs among service providers and difficulty communicating PADs to inpatient staff limited their usefulness (Kim 2007).
For policy makers
There are limited data available from which to inform policy. However, high intensity advance directives, such as joint crisis planning, may offer promise. Although not an outcome of this review, the Henderson 2004 study also reported that use of a joint crisis plan was associated with lower costs on average than usual care, although the differences did not reach statistical significance (Flood 2006) . Intensive advance directives, such as joint crisis planning, may provide a more promising alternative to controversial community treatment orders.
Implications for research 1. General This review highlighted the need for good quality randomised controlled trials to assess the effectiveness of advance directives in the mental health setting. Better reporting of both the included and excluded studies would have meant that more data were available for this review. Future studies should fully comply with CON-SORT guidance (Moher 2001).
Specific
More randomised controlled trials are required, investigating the differing levels of intensity associated with various types of advance directives. Future trials must be adequately powered for a variety of outcomes, including compulsory and voluntary admissions (number of admissions and lengths of stay), social functioning, mental state, quality of life, and satisfaction with mental health services, both in the short and long term. One suggested design for a study is outlined in Table 1 . Additionally, further study is required to measure whether advance directives accurately represent patient wishes. Interventions Intervention: participants provided with a booklet containing seven statements concerning preferences for future treatment; patients were encouraged to complete and sign the booklets, or dictate their preferences to the researcher; copies were provided to the key worker, general practitioner, and filed with the hospital and general practice records; all patients received standard community psychiatric care (planned and provided by a multidisciplinary community psychiatric team 
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